AstraZeneca Plc
Q1 2023 Earnings Call
Apr 27, 2023, 6:45 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe. And good evening to those listening in Asia.
Welcome, ladies and gentlemen, to AstraZeneca's Q1 2023 results webinar for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement. The company intends to utilize the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.
Although we believe our expectations are based on reasonable assumptions, by their very nature, the forward-looking statements involve risks and uncertainties, and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements made on this call reflect the knowledge and information available at the time of this call. The company undertakes no obligation to update forward-looking statements. Please also carefully review the forward-looking statements disclaimer in the slide deck that accompanies this presentation.
There will be an opportunity to ask questions after today's presentations. [Operator instructions] And with that, I would now hand you over to the company.
Andy Barnett -- Head of Investor Relations
Thank you, operator, and good afternoon, everyone. It's Andy Barnett here, head of investor relations at AstraZeneca. And I'm very pleased to welcome you to AstraZeneca's first quarter 2023 conference call. As usual, all materials presented are available on our website.
This slide contains our usual safe harbor statement. We will be making comments on our performance using constant exchange rates, or CER; core financial numbers; and other non-GAAP measures. A non-GAAP to GAAP reconciliation is contained within the results announcement. Numbers today are in millions of U.S.
dollars unless otherwise stated. This slide shows our agenda for today's call. Following prepared remarks, we will open the lineup for questions. We will try and address as many questions as we can during the allotted time, although I would ask that participants limit the number of questions you ask to allow others a fair chance to participate in the Q&A.